Oncology
Patients are our inspiration as we continue to pursue the fight against cancer.
Our focus on cancer research and treatments
We’re committed to advancing cancer research with one of the largest development programs in the industry across more than 30 tumour types. Key areas of research include bladder cancer, blood cancer, breast cancer, gastrointestinal (GI) cancers, gynecological cancers, head and neck cancer, lung cancer, melanoma, prostate cancer and renal cell carcinoma.
Our oncology discovery and development efforts
We’re following the science to discover innovations that can help patients no matter what stage of cancer they have, or so they may never be diagnosed with some types at all.
Immuno-oncology
Boosting anti-tumour responses by combining foundational cancer treatments with negative immune regulators that play different roles in adjusting the immune response.
Tissue targeting
Tissue-specific targeting of chemotherapy to increase cancer cell sensitivity to immune responses.
Precision molecular targeting
Impacting pathways that can drive cancer growth by identifying opportunities for the direct targeting of cancer cell vulnerabilities and transcription factors.
AU-NON-00909 Updated February 2026